EUVIMEDOpdag EUVIMED
Open access

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction

Baile Zuo, Lin Wang, Xiaoyan Li, Xin Li, Jinping Wang, Yanlu Xiong, Jie Lei, Xi Zhang, Yifan Chen, Qiongwen Liu, Jinke Jiao, Mengru Sui and 4 more

Aging · 2023

DOI: 10.18632/aging.205191 ↗

At a glance

Journal article in Aging, 2023. Written by Baile Zuo and 15 co-authors. Institution: Henan Key Laboratory of Immunology and Targeted Drugs, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan, China. Major MEDLINE topics: Lung Neoplasms, Adenocarcinoma of Lung. Cited 11 times so far (Crossref); 40 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The abnormality of surfactant protein C (SFTPC) has been linked to the development of a number of interstitial lung diseases, according to mounting evidence. Nonetheless, the function and mechanism of SFTPC in the biological progression of lung adenocarcinoma (LUAD) remain unclear. Analysis of public datasets and testing of clinical samples suggested that SFTPC expression was abnormally low in LUAD, which was associated with the onset and poor prognosis of LUAD. The SFTPC-related risk score was derived using least absolute shrinkage and selection operator Cox regression as well as multivariate Cox regression. The risk score was highly correlated with tumor purity and tumor mutation burden, and it could serve as an independent prognostic indicator for LUAD. Low-risk LUAD patients may benefit more from CTLA-4 or/and PD-1 inhibitors. Overall, the risk score is useful for LUAD patient prognostication and treatment guidance. Moreover, in vitro and in vivo experiments demonstrated that SFTPC inhibits the proliferation of LUAD by inhibiting PI3K/AKT/mTOR signaling transduction. These results reveal the molecular mechanism by which SFTPC inhibits the proliferation of LUAD and suggest that SFTPC could be a new therapeutic target for LUAD.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCell ProliferationTOR Serine-Threonine KinasesGene Expression Regulation, NeoplasticPulmonary Surfactant-Associated Protein C

Author keywords

PI3K/AKT/mTOR signalingSFTPClung adenocarcinomaprognosisproliferation

Substances

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesSFTPC protein, humanPulmonary Surfactant-Associated Protein C

Authors and institutions

  • Henan Key Laboratory of Immunology and Targeted Drugs, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan, China.
  • Department of Geriatrics, Xijing Hospital, The Air Force Military Medical University, Xi’an, Shaanxi, China.
  • Department of Blood Transfusion, Shanxi Provincial People’s Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Geriatric Medicine, Shanxi Provincial People’s Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Ultrasound, Shanxi Provincial People’s Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China.

Cite

APA

Zuo, B., Wang, L., Li, X., Li, X., Wang, J., Xiong, Y., Lei, J., Zhang, X., Chen, Y., Liu, Q., Jiao, J., Sui, M., Fan, J., Wu, N., Song, Z., & Li, G. (2023). Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction. Aging. https://doi.org/10.18632/aging.205191

Vancouver

Zuo B, Wang L, Li X, Li X, Wang J, Xiong Y, et al. Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction. Aging. 2023. doi:10.18632/aging.205191

BibTeX
@article{Zuo2023,
  author = {Zuo, Baile and Wang, Lin and Li, Xiaoyan and Li, Xin and Wang, Jinping and Xiong, Yanlu and Lei, Jie and Zhang, Xi and Chen, Yifan and Liu, Qiongwen and Jiao, Jinke and Sui, Mengru and Fan, Jinhan and Wu, Ningxue and Song, Zewen and Li, Guoyin},
  title = {Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205191}
}
Start for free →